Taniguchi Masahiko, Bollen Andrew W, Drasner Kenneth
Departmentof Anesthesiology and Perioperative Care, University of California, San Francisco, USA.
Anesthesiology. 2004 Jan;100(1):85-91. doi: 10.1097/00000542-200401000-00016.
Neurologic deficits after apparent intrathecal injection of 3% Nesacaine-CE intended for epidural administration created concern about the potential toxicity of chloroprocaine and the preservative sodium bisulfite. Although bisulfite-free formulations of chloroprocaine were subsequently introduced into clinical practice, the relative toxicities of this anesthetic and preservative were never clearly established. The current studies used a relevant functional and histologic model to investigate the intrathecal neurotoxicity of these two compounds.
In the first experiment, rats implanted with intrathecal catheters were given one of two commercially available solutions of chloroprocaine, one of which contained sodium bisulfite; control animals received saline. Animals were assessed for sensory impairment 7 days after administration using the tail-flick test and were killed to obtain histologic specimens to quantify nerve injury. In the second experiment, identical methodology was used to investigate the effects of freshly prepared solutions of chloroprocaine, chloroprocaine with sodium bisulfite, sodium bisulfite, and saline.
The two experiments yielded similar results. In experiment 1, tail-flick latencies and nerve injury scores after administration of plain chloroprocaine were significantly greater than those of chloroprocaine containing bisulfite. Injury scores for animals receiving chloroprocaine with bisulfite were elevated compared with those for animals given saline. In experiment 2, animals receiving plain chloroprocaine developed elevations in tail-flick latencies and nerve injury scores that were significantly greater than those for all other groups. Nerve injury scores with chloroprocaine containing bisulfite were greater than with saline or bisulfite alone. Tail-flick latencies and nerve injury scores with bisulfite alone were similar to those with saline.
Clinical deficits associated with unintentional intrathecal injection of chloroprocaine likely resulted from a direct effect of the anesthetic, not the preservative. The data also suggest that bisulfite can reduce neurotoxic damage induced by intrathecal local anesthetic.
明显将用于硬膜外给药的3%奴夫卡因-CE鞘内注射后出现神经功能缺损,引发了对氯普鲁卡因及防腐剂亚硫酸氢钠潜在毒性的关注。尽管不含亚硫酸氢钠的氯普鲁卡因制剂随后被引入临床实践,但这种麻醉剂和防腐剂的相对毒性从未明确确定。当前的研究使用了相关的功能和组织学模型来研究这两种化合物的鞘内神经毒性。
在第一个实验中,给植入鞘内导管的大鼠注射两种市售氯普鲁卡因溶液中的一种,其中一种含有亚硫酸氢钠;对照动物注射生理盐水。给药7天后,使用甩尾试验评估动物的感觉功能障碍,并将其处死以获取组织学标本,对神经损伤进行定量分析。在第二个实验中,采用相同的方法来研究新配制的氯普鲁卡因溶液、含亚硫酸氢钠的氯普鲁卡因溶液、亚硫酸氢钠溶液和生理盐水的作用。
两个实验得出了相似的结果。在实验1中,注射普通氯普鲁卡因后的甩尾潜伏期和神经损伤评分显著高于含亚硫酸氢钠的氯普鲁卡因。与注射生理盐水的动物相比,接受含亚硫酸氢钠氯普鲁卡因的动物损伤评分有所升高。在实验2中,接受普通氯普鲁卡因的动物甩尾潜伏期延长和神经损伤评分升高,显著高于所有其他组。含亚硫酸氢钠氯普鲁卡因的神经损伤评分高于生理盐水或单独使用亚硫酸氢钠组。单独使用亚硫酸氢钠的甩尾潜伏期和神经损伤评分与生理盐水组相似。
与意外鞘内注射氯普鲁卡因相关的临床功能缺损可能是由麻醉剂的直接作用导致的,而非防腐剂。数据还表明,亚硫酸氢钠可减轻鞘内局部麻醉剂引起的神经毒性损伤。